BioSpace News Archive

Deals

Free Technical Research Reports on Biotech Stocks -- Alkermes, Alnylam Pharma, Altimmune, and Alexion Pharma

On Monday, July 23, 2018, the NASDAQ Composite closed the trading session at 7,841.87, up 0.28%; the Dow Jones Industrial Average edged 0.06% lower, to finish at 25,044.29; and the S&P 500 closed at 2,806.98, slightly advancing 0.18%.

July 24, 2018
·
7 min read
Nucleix Announces Publication of Non-Invasive Bladder Cancer Recurrence Detection Study Showing Best-in-Class Performance

Results of the European multi-center study of Bladder EpiCheck™ urine test, supporting reduction of invasive procedures, were published in the European Urology Oncology journal

July 24, 2018
·
4 min read
Business

Delphi Behavioral Health Group Announces Opening of New Perspectives

Leading Health Group Adds New South Florida Outpatient Treatment Facility

July 24, 2018
·
3 min read
Business

Soligenix Announces Appointment of Mark Pearson to its Board of Directors

Soligenix intends to leverage Mr. Pearson’s extensive business and investing experience

July 24, 2018
·
6 min read
Drug Development

Janssen Presents Switch Data for New HIV-1 Treatment SYMTUZA™ (D/C/F/TAF) and Second Study Supporting its Use in a Rapid Initiation Scenario

Phase 3 EMERALD and DIAMOND studies at AIDS 2018 reinforce the safety and efficacy of the first darunavir-based HIV-1 single-tablet regimen

July 24, 2018
·
15 min read
Business

Center for Infectious Disease Research to Join Seattle Children’s Research Institute

Combined scientific team will form largest pediatric infectious disease research program in the U.S.

July 24, 2018
·
5 min read
Business

Cardurion Pharmaceuticals Appoints Rebecca Frey as Chief Operating Officer

Cardurion Pharmaceuticals, today announced that it has expanded its leadership team with the addition of chief operating officer, Rebecca V. Frey, Pharm.D.

July 24, 2018
·
4 min read
Business

PPD Names Ron Garrow as Chief Human Resource Officer

In this role, he will provide leadership for the company’s global human resources function, with a focus on talent management and development, cultural transformation, and employee engagement and retention.

July 24, 2018
·
3 min read
Business

XTL Biopharmaceuticals Reports First Half 2018 Financial Results & Provides Update

The Company is expanding its IP portfolio surrounding hCDR1 and has decided to reduce its research and development expenditures in connection with execution of its clinical trials.

July 24, 2018
·
10 min read
Genetown

Allurion Technologies Completes Enrollment in Landmark Pivotal U.S. Clinical Trial for the Elipse® Balloon

Enrollment surpasses 400-patient goal; topline results expected in early 2019

July 24, 2018
·
3 min read